scPharmaceuticals Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16.0M | 11.8M | 12.2M | 10.0M | 8.1M | 6.1M | 6.1M | 3.8M |
| Cost of Goods Sold | 5.0M | 3.5M | 4.0M | 3.3M | 2.3M | 1.8M | 1.8M | 1.1M |
| Gross Profit | 11.0M | 8.3M | 8.2M | 6.7M | 5.8M | 4.3M | 4.3M | 2.7M |
| R&D Expenses | 4.1M | 4.6M | 3.2M | 3.5M | 2.7M | 2.7M | 3.3M | 3.4M |
| Operating Expenses | 25.3M | 26.0M | 24.5M | 24.9M | 20.2M | 20.1M | 19.6M | 17.6M |
| Operating Income | -14.3M | -17.8M | -16.3M | -18.1M | -14.4M | -15.9M | -15.3M | -14.8M |
| Other Income / Gains | -3.7M | -2.0M | -2.5M | -17.0M | -2.7M | 1.7M | 1.4M | -795K |
| Net Income | -18.0M | -19.7M | -18.8M | -35.1M | -17.1M | -14.1M | -13.8M | -15.6M |
| EPS (Diluted) | -0.34 | -0.37 | -0.42 | -0.75 | -0.44 | -0.36 | -0.36 | -0.40 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.688 | 0.705 | 0.674 | 0.67 | 0.714 | 0.699 | 0.709 | 0.716 |
| General And Administrative Expenses | 0 | 21.0M | 1.1M | 0 | 0 | 1.1M | 23.0M | 7.4M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 16.3M | -6.8M | 0 |
| Selling General And Administrative Expenses | 21.2M | 21.4M | 21.4M | 21.3M | 17.5M | 17.4M | 16.2M | 14.1M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 30.3M | 29.5M | 28.5M | 28.2M | 22.5M | 22.0M | 21.4M | 18.6M |
| Interest Income | 509K | 716K | 1.0M | 903K | 664K | 877K | 1.1M | 1.3M |
| Interest Expense | 1.4M | 1.4M | 1.5M | 1.9M | 2.1M | 2.1M | 2.1M | 2.1M |
| Depreciation And Amortization | 64K | 63K | 4K | -87K | 52K | 51K | 140K | 272K |
| Ebitda | -16.6M | -18.3M | -17.4M | -33.3M | -14.9M | -12.0M | -11.6M | -13.3M |
| Ebitdaratio | -1.032 | -1.557 | -1.428 | -3.316 | -1.851 | -1.959 | -1.90 | -3.504 |
| Operating Income Ratio | -0.891 | -1.511 | -1.345 | -1.81 | -1.792 | -2.598 | -2.503 | -3.909 |
| Income Before Tax | -18.0M | -19.7M | -18.8M | -35.1M | -17.1M | -14.1M | -13.8M | -15.6M |
| Income Before Tax Ratio | -1.124 | -1.68 | -1.551 | -3.501 | -2.122 | -2.312 | -2.266 | -4.119 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -1.124 | -1.68 | -1.551 | -3.501 | -2.122 | -2.312 | -2.266 | -4.119 |
| Epsdiluted | -0.34 | -0.37 | -0.42 | -0.75 | -0.44 | -0.36 | -0.36 | -0.40 |
| Weighted Average Shs Out | 53.7M | 53.7M | 44.5M | 46.6M | 39.0M | 39.0M | 38.8M | 38.8M |
| Weighted Average Shs Out Dil | 53.7M | 53.7M | 44.5M | 46.6M | 39.0M | 39.0M | 38.8M | 38.8M |